NASDAQ:AXDX
Accelerate Diagnostics Stock News
$1.01
+0.0497 (+5.18%)
At Close: Mar 27, 2024
Accelerate Diagnostics (AXDX) Reports Q3 Loss, Lags Revenue Estimates
08:35pm, Tuesday, 09'th Nov 2021
Accelerate Diagnostics (AXDX) delivered earnings and revenue surprises of 57.14% and -11.05%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the s
Are These 2 Companies Next for Short Squeezes?
08:07am, Thursday, 21'st Oct 2021
SmileDirectClub and Accelerate Diagnostics are super cheap right now, with very high short positions. Here's why the shorts might rupture.
TUCSON, Ariz., Sept. 23, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced that it has entered into separate, privately negotiated exchange agreements with certain hold
Accelerate Diagnostics, Inc. (AXDX) CEO Jack Phillips on Q2 2021 Results - Earnings Call Transcript
10:51am, Sunday, 08'th Aug 2021
Accelerate Diagnostics, Inc. (AXDX) CEO Jack Phillips on Q2 2021 Results - Earnings Call Transcript
Accelerate Diagnostics (AXDX) Reports Q2 Loss, Misses Revenue Estimates
10:03pm, Thursday, 05'th Aug 2021
Accelerate Diagnostics (AXDX) delivered earnings and revenue surprises of -2.86% and -12.37%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Accelerate Diagnostics (AXDX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
04:44pm, Thursday, 29'th Jul 2021
Accelerate Diagnostics (AXDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Accelerate Diagnostics Schedules Call to Review 2nd Quarter 2021 Results
08:00am, Thursday, 15'th Jul 2021
TUCSON, Ariz., July 15, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. announced today that management will host a conference call on Thursday, August 5, 2021, at 4:30 p.m.
Up 6% in June, Is Accelerate Diagnostics a Good Buy Now?
06:31am, Thursday, 08'th Jul 2021
Investors were encouraged by a recent award the company received in the effort to diagnose and treat sepsis more rapidly.
Accelerate Diagnostics Launches a Fast Antimicrobial Susceptibility Test for Use with Existing ID Systems in the United States
08:00am, Wednesday, 07'th Jul 2021
TUCSON, Ariz., July 7, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today announced the launch of a new IVD configuration of its Accelerate PhenoTest® BC kit in the United States.
New Accelerate Pheno® Landmark Study Validates Important Clinical Benefits to Be Presented at ECCMID 2021
10:05am, Wednesday, 30'th Jun 2021
TUCSON, Ariz., June 30, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today announced that it will have 3 data presentations from its Improving Outcomes and Antibiotic Stewardship (
New Strong Sell Stocks for June 2nd
12:47pm, Wednesday, 02'nd Jun 2021
BEP, AXDX, FURY, KBAL, and LUNA have been added to the Zacks Rank #5 (Strong Sell) List on June 2, 2021
New Strong Sell Stocks for May 20th
09:46am, Thursday, 20'th May 2021
AXDX, CRIS, FSTR, GO, and PRLB have been added to the Zacks Rank #5 (Strong Sell) List on May 20, 2021
Accelerate Diagnostics to Participate in William Blair 41st Annual Growth Stock Conference on June 3, 2021
08:00am, Wednesday, 19'th May 2021
TUCSON, Ariz., May 19, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that Chief Executive Officer, Jack Phillips, and Chief Financial Officer, Steve Reichling, wil
New Strong Sell Stocks for May 14th
09:46am, Friday, 14'th May 2021
AXDX, CDR, FPAY, GCI, and IRTC have been added to the Zacks Rank #5 (Strong Sell) List on May 14, 2021
Accelerate Diagnostics, Inc. (AXDX) CEO Jack Phillips on Q1 2021 Results - Earnings Call Transcript
10:32pm, Thursday, 06'th May 2021
Accelerate Diagnostics, Inc. (AXDX) CEO Jack Phillips on Q1 2021 Results - Earnings Call Transcript